LOS ANGELES, Nov 7 (Reuters) - Early results from an ongoing study showed that people with newly diagnosed rheumatoid arthritis were more likely to reach clinical remission with Amgen Inc and Wyeth's ...
THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., June 20, 2003 – Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced results of a new study assessing the ...
SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
Combining a new drug with the standard initial treatment for rheumatoid arthritis seems to work better than using either medicine alone, research indicates. About 1 percent of people have rheumatoid ...
KENILWORTH, N.J. & SEOUL, South Korea--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced that pivotal Phase 3 clinical studies of SB4, ...
COLLEGEVILLE, Pa., and THOUSAND OAKS, Calif. A study has found that when given early in the onset of rheumatoid arthritis in combination with other therapies, Amgen’s drug Enbrel (etanercept) can ...
WILMINGTON, Del., Oct 28 (Reuters) - A British charitable trust filed a patent infringement suit against Wyeth and Amgen on Wednesday over their blockbuster Enbrel drug, one of the world's ...
If you’re looking at treatment options for certain kinds of psoriasis or arthritis, you may want to learn more about Enbrel (etanercept). The active ingredient in Enbrel is etanercept. An active ...
The FINANCIAL — Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. on June 10 announced that pivotal Phase 3 clinical studies of SB4, an investigational biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results